EA006940B1 - Применение opgl и его аналогов для отрицательной регуляции opgl в организме животного - Google Patents

Применение opgl и его аналогов для отрицательной регуляции opgl в организме животного Download PDF

Info

Publication number
EA006940B1
EA006940B1 EA200100356A EA200100356A EA006940B1 EA 006940 B1 EA006940 B1 EA 006940B1 EA 200100356 A EA200100356 A EA 200100356A EA 200100356 A EA200100356 A EA 200100356A EA 006940 B1 EA006940 B1 EA 006940B1
Authority
EA
Eurasian Patent Office
Prior art keywords
seeg
cell
animal
bei
polypeptide
Prior art date
Application number
EA200100356A
Other languages
English (en)
Russian (ru)
Other versions
EA200100356A1 (ru
Inventor
Торбен Халькиер
Йеспер Хонинг
Original Assignee
Фармэкса А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармэкса А/С filed Critical Фармэкса А/С
Priority claimed from PCT/DK1999/000481 external-priority patent/WO2000015807A1/en
Publication of EA200100356A1 publication Critical patent/EA200100356A1/ru
Publication of EA006940B1 publication Critical patent/EA006940B1/ru

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EA200100356A 1998-09-15 1999-09-13 Применение opgl и его аналогов для отрицательной регуляции opgl в организме животного EA006940B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199801164 1998-09-15
US10289698P 1998-10-02 1998-10-02
PCT/DK1999/000481 WO2000015807A1 (en) 1998-09-15 1999-09-13 Method for down-regulating osteoprotegerin ligand activity

Publications (2)

Publication Number Publication Date
EA200100356A1 EA200100356A1 (ru) 2001-08-27
EA006940B1 true EA006940B1 (ru) 2006-06-30

Family

ID=27675500

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100356A EA006940B1 (ru) 1998-09-15 1999-09-13 Применение opgl и его аналогов для отрицательной регуляции opgl в организме животного

Country Status (4)

Country Link
CN (1) CN101260152A (sr)
EA (1) EA006940B1 (sr)
RS (1) RS49960B (sr)
ZA (1) ZA200102131B (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019061297A1 (zh) * 2017-09-29 2019-04-04 苏州工业园区唯可达生物科技有限公司 一种cd4辅助性t细胞表位融合肽及其疫苗
CN110923266A (zh) * 2019-11-07 2020-03-27 苏州工业园区唯可达生物科技有限公司 一种重组病毒载体、包含其的免疫组合物以及用途

Also Published As

Publication number Publication date
RS49960B (sr) 2008-09-29
YU19701A (sh) 2005-06-10
ZA200102131B (en) 2002-06-14
EA200100356A1 (ru) 2001-08-27
CN101260152A (zh) 2008-09-10

Similar Documents

Publication Publication Date Title
ES2239457T3 (es) Procedimiento para regular a niveles mas bajos la actividad de ligando de osteoprotegerina.
AU2010212381B2 (en) Novel method for down-regulation of amyloid
US7070784B1 (en) Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues
EA008762B1 (ru) АНАЛОГ АУТОЛОГИЧНОГО Аβ ИЛИ АРР ЖИВОТНОГО И СПОСОБЫ ЕГО ПРИМЕНЕНИЯ
JP2001521386A (ja) 被修飾ＴＮＦα分子、このような被修飾ＴＮＦα分子をコードするＤＮＡ、並びにこのような被修飾ＴＮＦα分子及びＤＮＡを具備するワクチン
TW202039587A (zh) 供合成胜肽免疫原作為免疫刺激劑的人工混雜t輔助細胞抗原決定位
MXPA06009805A (es) Peptidos de interleucina 1 beta y factor de necrosis tumoral alfa y metodo de tratamiento utilizando los mismos.
US20020172673A1 (en) Method for down-regulating IgE
JP2005518194A (ja) 乱交雑ｔ細胞エピトープ挿入物を有するマルチマータンパク質の免疫原性擬態物
US20050063952A1 (en) Immunogenic CEA
EP1874332A2 (en) Immunogenic egfr peptides comprising foreign t cell stimulating epitope
EA006940B1 (ru) Применение opgl и его аналогов для отрицательной регуляции opgl в организме животного
WO2009003889A2 (en) Immunogenic analogues of rankl
JP2007523605A (ja) 細胞毒性が低減された免疫原性ヒトＴＮＦαアナログおよびそれらの製造方法
EP1541587A2 (en) Method for down-regulating osteoprotegerin ligand activity

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU